BIO 2020
Investors are no longer meeting new partners face to face, but primed funds and new demand for converging digital products still fuel new deals.
Large health tech customers are more cautious and overwhelmed than ever, which means that many younger digital health startups will face an uphill battle selling their products in the months to come.